Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Infection and Immunity logoLink to Infection and Immunity
. 1997 Apr;65(4):1387–1394. doi: 10.1128/iai.65.4.1387-1394.1997

Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

P A Kozlowski 1, S Cu-Uvin 1, M R Neutra 1, T P Flanigan 1
PMCID: PMC175144  PMID: 9119478

Abstract

To determine which mucosal immunization routes may be optimal for induction of antibodies in the rectum and female genital tract, groups of women were immunized a total of three times either orally, rectally, or vaginally with a cholera vaccine containing killed Vibrio cholerae cells and the recombinant cholera toxin B (CTB) subunit. Systemic and mucosal antibody responses were assessed at 2-week intervals by quantitation of CTB-specific antibodies in serum and in secretions collected directly from mucosal surfaces of the oral cavity, rectum, cervix, and vagina with absorbent wicks. The three immunization routes increased levels of specific immunoglobulin G (IgG) in serum and specific IgA in saliva to similar extents. Rectal immunization was superior to other routes for inducing high levels of specific IgA and IgG in rectal secretions but was least effective for generating antibodies in female genital tract secretions. Only vaginal immunization significantly increased both specific IgA and specific IgG in both the cervix and the vagina. In addition, local production of CTB-specific IgG in the genital tract could be demonstrated only in vaginally immunized women. Vaginal immunization did not generate antibodies in the rectum, however. Thus, generation of optimal immune responses to sexually transmitted organisms in both the rectal and the genital mucosae of women may require local immunization at both of these sites.

Full Text

The Full Text of this article is available as a PDF (159.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cui Z. D., Tristram D., LaScolea L. J., Kwiatkowski T., Jr, Kopti S., Ogra P. L. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun. 1991 Apr;59(4):1465–1469. doi: 10.1128/iai.59.4.1465-1469.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Delacroix D. L., Dehennin J. P., Vaerman J. P. Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays. J Immunol Methods. 1982;48(3):327–337. doi: 10.1016/0022-1759(82)90333-7. [DOI] [PubMed] [Google Scholar]
  3. Forrest B. D. Effects of sample processing on the measurement of specific intestinal IgA immune responses. Vaccine. 1992;10(11):802–805. doi: 10.1016/0264-410x(92)90517-n. [DOI] [PubMed] [Google Scholar]
  4. Forrest B. D., Shearman D. J., LaBrooy J. T. Specific immune response in humans following rectal delivery of live typhoid vaccine. Vaccine. 1990 Jun;8(3):209–212. doi: 10.1016/0264-410x(90)90047-p. [DOI] [PubMed] [Google Scholar]
  5. Haneberg B., Kendall D., Amerongen H. M., Apter F. M., Kraehenbuhl J. P., Neutra M. R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun. 1994 Jan;62(1):15–23. doi: 10.1128/iai.62.1.15-23.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hocini H., Barra A., Bélec L., Iscaki S., Preud'homme J. L., Pillot J., Bouvet J. P. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand J Immunol. 1995 Aug;42(2):269–274. doi: 10.1111/j.1365-3083.1995.tb03653.x. [DOI] [PubMed] [Google Scholar]
  7. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A. M. Mucosal immunity: implications for vaccine development. Immunobiology. 1992 Feb;184(2-3):157–179. doi: 10.1016/S0171-2985(11)80473-0. [DOI] [PubMed] [Google Scholar]
  8. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 1993 Sep;11(12):1179–1184. doi: 10.1016/0264-410x(93)90039-z. [DOI] [PubMed] [Google Scholar]
  9. Hopkins S., Kraehenbuhl J. P., Schödel F., Potts A., Peterson D., de Grandi P., Nardelli-Haefliger D. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun. 1995 Sep;63(9):3279–3286. doi: 10.1128/iai.63.9.3279-3286.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hordnes K., Tynning T., Kvam A. I., Jonsson R., Haneberg B. Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women. Infect Immun. 1996 May;64(5):1643–1652. doi: 10.1128/iai.64.5.1643-1652.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jain S. L., Barone K. S., Flanagan M. P., Michael J. G. Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen. Vaccine. 1996 Jan;14(1):42–48. doi: 10.1016/0264-410x(95)00158-w. [DOI] [PubMed] [Google Scholar]
  12. Jertborn M., Svennerholm A. M., Holmgren J. Evaluation of different immunization schedules for oral cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine. 1993;11(10):1007–1012. doi: 10.1016/0264-410x(93)90125-h. [DOI] [PubMed] [Google Scholar]
  13. Jertborn M., Svennerholm A. M., Holmgren J. Safety and immunogenicity of an oral recombinant cholera B subunit-whole cell vaccine in Swedish volunteers. Vaccine. 1992;10(2):130–132. doi: 10.1016/0264-410x(92)90030-n. [DOI] [PubMed] [Google Scholar]
  14. Kilian M., Mestecky J., Russell M. W. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev. 1988 Jun;52(2):296–303. doi: 10.1128/mr.52.2.296-303.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kozlowski P. A., Chen D., Eldridge J. H., Jackson S. Contrasting IgA and IgG neutralization capacities and responses to HIV type 1 gp120 V3 loop in HIV-infected individuals. AIDS Res Hum Retroviruses. 1994 Jul;10(7):813–822. doi: 10.1089/aid.1994.10.813. [DOI] [PubMed] [Google Scholar]
  16. Kraehenbuhl J. P., Neutra M. R. Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev. 1992 Oct;72(4):853–879. doi: 10.1152/physrev.1992.72.4.853. [DOI] [PubMed] [Google Scholar]
  17. Kraehenbuhl J. P., Neutra M. R. Transepithelial transport and mucosal defence II: secretion of IgA. Trends Cell Biol. 1992 Jun;2(6):170–174. doi: 10.1016/0962-8924(92)90036-m. [DOI] [PubMed] [Google Scholar]
  18. Langman J. M., Rowland R. The number and distribution of lymphoid follicles in the human large intestine. J Anat. 1986 Dec;149:189–194. [PMC free article] [PubMed] [Google Scholar]
  19. Lehner T., Bergmeier L. A., Panagiotidi C., Tao L., Brookes R., Klavinskis L. S., Walker P., Walker J., Ward R. G., Hussain L. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science. 1992 Nov 20;258(5086):1365–1369. doi: 10.1126/science.1360702. [DOI] [PubMed] [Google Scholar]
  20. Lehner T., Brookes R., Panagiotidi C., Tao L., Klavinskis L. S., Walker J., Walker P., Ward R., Hussain L., Gearing J. H. T- and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8638–8642. doi: 10.1073/pnas.90.18.8638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lue C., van den Wall Bake A. W., Prince S. J., Julian B. A., Tseng M. L., Radl J., Elson C. O., Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol. 1994 May;96(2):356–363. doi: 10.1111/j.1365-2249.1994.tb06567.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McDermott M. R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol. 1979 May;122(5):1892–1898. [PubMed] [Google Scholar]
  23. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  24. Mestecky J., Jackson S. Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol. 1994 Sep;14(5):259–272. doi: 10.1007/BF01540979. [DOI] [PubMed] [Google Scholar]
  25. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  26. Moldoveanu Z., Clements M. L., Prince S. J., Murphy B. R., Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine. 1995 Aug;13(11):1006–1012. doi: 10.1016/0264-410x(95)00016-t. [DOI] [PubMed] [Google Scholar]
  27. Nashar T. O., Hirst T. R. Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB). Vaccine. 1995 Jun;13(9):803–810. doi: 10.1016/0264-410x(94)00077-z. [DOI] [PubMed] [Google Scholar]
  28. Neutra M. R., Pringault E., Kraehenbuhl J. P. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol. 1996;14:275–300. doi: 10.1146/annurev.immunol.14.1.275. [DOI] [PubMed] [Google Scholar]
  29. Ogra P. L., Karzon D. T. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol. 1969 Jun;102(6):1423–1430. [PubMed] [Google Scholar]
  30. Ogra P. L., Ogra S. S. Local antibody response to poliovaccine in the human female genital tract. J Immunol. 1973 May;110(5):1307–1311. [PubMed] [Google Scholar]
  31. Pierce N. F., Cray W. C., Jr Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats. J Immunol. 1982 Mar;128(3):1311–1315. [PubMed] [Google Scholar]
  32. Saltzman W. M., Radomsky M. L., Whaley K. J., Cone R. A. Antibody diffusion in human cervical mucus. Biophys J. 1994 Feb;66(2 Pt 1):508–515. doi: 10.1016/s0006-3495(94)80802-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Srinivasan J., Tinge S., Wright R., Herr J. C., Curtiss R., 3rd Oral immunization with attenuated Salmonella expressing human sperm antigen induces antibodies in serum and the reproductive tract. Biol Reprod. 1995 Aug;53(2):462–471. doi: 10.1095/biolreprod53.2.462. [DOI] [PubMed] [Google Scholar]
  34. Tjokronegoro A., Sirisinha S. Quantitative analysis of immunoglobulins and albumin in secretion of female reproductive tract. Fertil Steril. 1975 May;26(5):413–417. doi: 10.1016/s0015-0282(16)41112-x. [DOI] [PubMed] [Google Scholar]
  35. Wassén L., Schön K., Holmgren J., Jertborn M., Lycke N. Local intravaginal vaccination of the female genital tract. Scand J Immunol. 1996 Oct;44(4):408–414. doi: 10.1046/j.1365-3083.1996.d01-320.x. [DOI] [PubMed] [Google Scholar]
  36. Zhou F., Kraehenbuhl J. P., Neutra M. R. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine. 1995 May;13(7):637–644. doi: 10.1016/0264-410x(94)00029-m. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES